Dr SCHNEIDER Christophe

Fiche personne

Coordonnées

UMR CNRS/URCA 7369 MEDyC
UFR Sciences Exactes et Naturelles
Campus du Moulin de la Housse
BP 1039
51687 REIMS Cedex 2

03 26 91 85 99

Territoire

Champagne-Ardenne

Statut

Ingénieur/Technicien

Affiliation

Université de Reims Champagne-Ardenne (URCA)

UMR CNRS 7369 MEDyC - Matrice Extracellulaire et Dynamique Cellulaire MEDyC (MEDyC)

Équipes/plateformes

UMR 7369 MEDyC - Equipe "Matrice extracellulaire, Cancer et Cibles thérapeutiques"

Recherche

Mots clés : Biologie Moléculaire, LRP-1, cancer

Publications

In Silico Prediction of Tetrastatin-Derived Peptide Interactions with αvβ3 and α5β1 Integrins.

Paturel V, Baud S, Schneider C, Brassart-Pasco S

Pharmaceuticals (Basel). 2025 06 21;18(7):

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.

Moniot A, Schneider C, Chardin L, Yaniz-Galende E, Genestie C, Etiennot M, Henry A, Drelon C, Le Formal A, Langlois B, Venat L, Louvet C, Favier L, Lortholary A, Berton-Rigaud D, Dohollou N, Desauw C, Fabbro M, Malaurie E, Dubot C, Kurtz JE, Bonichon Lamichhane N, Pujade-Lauraine É, Jeanne A, Leary A, Dedieu S

Mol Cancer. 2024 08 14;23(1):166

Dynamized ultra-low dilution of disrupts plasma membrane organization and decreases migration of melanoma cancer cell.

Fuselier C, Dufay E, Berquand A, Terryn C, Bonnomet A, Molinari M, Martiny L, Schneider C

Cell Adh Migr. 2023 12;17(1):1-13

Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.

Sassi A, Fredon M, Cotte AK, Fuselier C, Schneider C, Martiny L, Monchaud D, Chekir-Ghedira L, Aires V, Delmas D

Cells. 2023 06 6;12(12):

[Pigmented macules].

Schneider C, Granel-Brocard F, Seiller H, Bursztejn AC

Rev Med Interne. 2023 06;44(6):321-323

LRP-1-dependent control of calpain expression and activity: A new mechanism regulating thyroid carcinoma cell adhesion.

Langlois B, Martin J, Schneider C, Hachet C, Terryn C, Rioult D, Martiny L, Théret L, Salesse S, Dedieu S

Front Oncol. 2022 08 16;12:981927

Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact.

Ben Arfi K, Schneider C, Bennasroune A, Bouland N, Wolak-Thierry A, Collin G, Le CC, Toussaint K, Hachet C, Lehrter V, Dedieu S, Bouché O, Morjani H, Boulagnon-Rombi C, Appert-Collin A

Cancers (Basel). 2022 Feb 13;14(4):

Role of Endocytosis Proteins in Gefitinib-Mediated EGFR Internalisation in Glioma Cells.

Cruz Da Silva E, Choulier L, Thevenard-Devy J, Schneider C, Carl P, Rondé P, Dedieu S, Lehmann M

Cells. 2021 Nov 21;10(11):

LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis.

Campion O, Thevenard Devy J, Billottet C, Schneider C, Etique N, Dupuy JW, Raymond AA, Boulagnon Rombi C, Meunier M, Djermoune EH, Lelièvre E, Wahart A, Bour C, Hachet C, Cairo S, Bikfalvi A, Dedieu S, Devy J

Biomedicines. 2021 Oct 9;9(10):

Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: an LOC network study.

Lam M, Touitou V, Choquet S, Cassoux N, Ghesquières H, Kodjikian L, Schmitt A, Gattoussi S, Tabouret É, Sampo M, Blonski M, Angioi-Duprez K, Houot R, Mouriaux F, Gyan E, Le Lez ML, Moles MP, Croisé F, Chauchet A, Schwartz C, Ahle G, Meyer L, Gressin R, Chiquet C, Oberic L, Ollé P, Marolleau JP, Jany B, Tempescul A, Cochener B, Damaj G, Quintyn JC, Chabrot C, Rousseau E, Franciane P, Schneider C, Massé H, Bonnefoy JT, Brézin A, Fornecker LM, Ballonzoli L, Le Garff-Tavernier M, Hoang-Xuan K, Bodaghi B, Soussain C, Houillier C

Am J Hematol. 2021 Apr 17;:

Adverse effects of oseltamivir phosphate therapy on the liver of LDLR-/- mice without any benefit on atherosclerosis and thrombosis.

Bocquet O, Wahart A, Sarazin T, Vincent E, Schneider C, Fougerat A, Gayral S, Henry A, Blaise S, Romier-Crouzet B, Boulagnon C, Jaisson S, Gillery PP, Bennasroune A, Sartelet H, Laffargue M, Martiny PL, Duca PL, Maurice P

J Cardiovasc Pharmacol. 2021 Feb 25;:

Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted on Melanoma.

Fuselier C, Quemener S, Dufay E, Bour C, Boulagnon-Rombi C, Bouland N, Djermoune EH, Devy J, Martiny L, Schneider C

Front Oncol. 2021 ;11:597503

Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.

Blandin AF, Cruz Da Silva E, Mercier MC, Glushonkov O, Didier P, Dedieu S, Schneider C, Devy J, Etienne-Selloum N, Dontenwill M, Choulier L, Lehmann M

Cell Mol Life Sci. 2020 Nov 5;:

Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression.

Campion O, Al Khalifa T, Langlois B, Thevenard-Devy J, Salesse S, Savary K, Schneider C, Etique N, Dedieu S, Devy J

Front Oncol. 2020 ;10:882

Low-diluted Phenacetinum disrupted the melanoma cancer cell migration.

Fuselier C, Terryn C, Berquand A, Crowet JM, Bonnomet A, Molinari M, Dauchez M, Martiny L, Schneider C

Sci Rep. 2019 Jun 24;9(1):9109

LRP1 expression in colon cancer predicts clinical outcome.

Boulagnon-Rombi C, Schneider C, Leandri C, Jeanne A, Grybek V, Bressenot AM, Barbe C, Marquet B, Nasri S, Coquelet C, Fichel C, Bouland N, Bonnomet A, Kianmanesh R, Lebre AS, Bouché O, Diebold MD, Bellon G, Dedieu S

Oncotarget. 2018 Feb 6;9(10):8849-8869